Malignant melanoma with BRAF V600 mutation

Malignant melanoma with BRAF V600 mutation is an aggressive neoplasm of the integumentary system arising from the oncogenic transformation of melanocytes, predominantly located in the skin

Malignant melanoma with BRAF V600 mutation is an aggressive neoplasm of the integumentary system arising from the oncogenic transformation of melanocytes, predominantly located in the skin Pathophysiologically, these alterations cause constitutive kinase activation of the intracellular mitogen-activated protein kinase (MAPK/ERK) signaling cascade This continuous signaling drives unchecked cellular proliferation, evasion of apoptosis, increased invasiveness, and high metastatic potential, charact...

This clinical state is defined by somatic activating mutations at codon 600 of the *BRAF* oncogene—most frequently BRAF V600E or V600K—which occur in approximately 40% to 50% of cutaneous melanomas

This clinical state is defined by somatic activating mutations at codon 600 of the *BRAF* oncogene—most frequently BRAF V600E or V600K—which occur in approximately 40% to 50% of cutaneous melanomas

This clinical state is defined by somatic activating mutations at codon 600 of the *BRAF* oncogene—most frequently BRAF V600E or V600K—which occur in approximately 40% to 50% of cutaneous melanomas

Pathophysiologically, these alterations cause constitutive kinase activation of the intracellular mitogen-activated protein kinase (MAPK/ERK) signaling cascade This continuous signaling drives unchecked cellular proliferation, evasion of apoptosis, increased invasiveness, and high metastatic potential, characterizing a distinct molecular subtype targeted by specific kinase inhibitor regimens

This continuous signaling drives unchecked cellular proliferation, evasion of apoptosis, increased invasiveness, and high metastatic potential, characterizing a distinct molecular subtype targeted by specific kinase inhibitor regimens